The National Institutes of Health has picked seven companies and academic centers to help develop digital health solutions aimed at the COVID-19 pandemic—including smartphone apps, wearables and big data programs to mitigate the personal and public health impacts of the novel coronavirus.
Each one-year contract includes two phases: an initial award for feasibility testing, followed by an option for additional development funding. If all seven progress to the second phase, the total value of awards would reach $22.8 million.
The selected projects include an effort by IBM to provide sophisticated digital contact tracing, alongside verifiable methods for reporting a person’s health status following exposure and testing.
Read more at Fierce Biotech.
